EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Investigation

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI63572PMID 23281395PMCID PMC3561811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clear cell sarcoma

  2014cited by this paper
• Knockdown of c‐Fos suppresses the growth of human colon carcinoma cells in athymic mice

  2012cited by this paper
• Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma

  2009cited by this paper
• Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin.

  2009cited by this paper
• c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.

  2008cited by this paper
• Clear cell sarcoma of tendons and aponeuroses

  2007cited by this paper
• A conditional mouse model of synovial sarcoma: insights into a myogenic origin.

  2007cited by this paper
• Efficient method to generate single‐copy transgenic mice by site‐specific integration in embryonic stem cells

  2006cited by this paper
• MITF: master regulator of melanocyte development and melanoma oncogene.

  2006cited by this paper
• Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.

  2006influential reference
• Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.

  2005cited by this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cited by this paper
• Inhibition of Platelet-derived Growth Factor-induced Cell Growth Signaling by a Short Interfering RNA for EWS-Fli1 via Down-regulation of Phospholipase D2 in Ewing Sarcoma Cells*

  2005cited by this paper
• Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

  2005cited by this paper
• EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.

  2005cited by this paper
• Clear-cell sarcoma of tendons and aponeuroses

  2004cited by this paper
• The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma

  2003cited by this paper
• Identification of target genes for EWS/ATF-1 chimeric transcription factor

  2003cited by this paper
• Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.

  2003cited by this paper
• Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

  2002cited by this paper
• Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.

  2002cited by this paper
• Clear cell sarcoma of tendons and aponeuroses in pediatric patients

  2002cited by this paper
• Addiction to Oncogenes--the Achilles Heal of Cancer

  2002cited by this paper
• Clear cell sarcoma: The Roswell Park experience

  2001cited by this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts).

  2001cited by this paper
• Clear Cell Sarcoma Shows Immunoreactivity for Microphthalmia Transcription Factor: Further Evidence for Melanocytic Differentiation

  2001cited by this paper
• Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

  2001cited by this paper
• Investigation

  2000cited by this paper
• Fate of the mammalian cardiac neural crest.

  2000cited by this paper
• Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis.

  2000cited by this paper
• Clear cell sarcoma.

  1999cited by this paper
• A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.

  1999cited by this paper
• Clear cell sarcoma (malignant melanoma) of soft parts

  1999cited by this paper
• The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly

  1998cited by this paper
• MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription

  1998cited by this paper
• Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II

  1998cited by this paper
• Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites.

  1998cited by this paper
• The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct

  1998cited by this paper
• A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.

  1997cited by this paper
• Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.

  1997cited by this paper
• The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.

  1996cited by this paper
• c-fos is required for malignant progression of skin tumors.

  1995cited by this paper
• Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

  1995cited by this paper
• Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.

  1995cited by this paper
• Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB.

  1994cited by this paper
• The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.

  1994cited by this paper
• Osteoblasts are target cells for transformation in c-fos transgenic mice

  1993cited by this paper
• A novel target cell for c‐fos‐induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras.

  1991cited by this paper
• Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts.

  1991cited by this paper
• Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis.

  1990cited by this paper
• Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

  1989cited by this paper
• Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.

  1988cited by this paper
• A cyclic AMP- and phorbol ester-inducible DNA element

  1986cited by this paper
• Identification of a cyclic-AMP-responsive element within the rat somatostatin gene.

  1986cited by this paper
• Clear cell sarcoma. A clinicopathologic study of 27 cases

  1983cited by this paper
• Clear-cell sarcoma of tendons and aponeuroses.

  1978cited by this paper
• Clear‐cell sarcoma of tendons and aponeuroses. An analysis of 21 cases

  1965cited by this paper

• Transcription Elongation Factor A (SII)-Like (TCEAL) Family Members: Re-Evaluation of Predicted Structure and Summary of Expression and Functions.

  2025cites this paper
• MAPK-targeted therapies in non-gastrointestinal stromal tumor soft tissue sarcomas: current landscape and future directions

  2025cites this paper
• Establishing preclinical models for clear cell sarcoma of soft tissue

  2025cites this paper
• AURKA/PLK1/CDC25C Axis as a Novel Therapeutic Target in INI1‐Deficient Epithelioid Sarcoma

  2025cites this paper
• Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas

  2024cites this paper
• Single-cell RNA profiling of the primary tumor and metastatic lymph node lesions in a patient with clear cell sarcoma of soft tissue: A case report

  2024cites this paper
• BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling

  2024cites this paper
• Expression, molecular mechanisms and therapeutic potentials of ATF1 in cancers.

  2024cites this paper
• Medical imaging for the diagnosis, recurrence and metastasis evaluation of clear cell sarcoma

  2024cites this paper
• Modeling sarcoma relevant translocations using CRISPR‐Cas9 in human embryonic stem derived mesenchymal precursors

  2023cites this paper
• EWSR1::ATF1 Orchestrates the Clear Cell Sarcoma Transcriptome in Human Tumors and a Mouse Genetic Model

  2023cites this paper
• Use of Next-Generation Sequencing Techniques in the Accurate Diagnosis of Neural Crest Cell-Derived Tumors

  2023cites this paper
• Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition

  2023cites this paper
• ATF1 promotes the malignancy of lung adenocarcinoma cells by transcriptionally regulating ZNF143 expression

  2023cites this paper
• Targeting epigenetic aberrations of sarcoma in CRISPR era

  2023cites this paper
• Clear cell sarcoma: state-of-the art and perspectives

  2023cites this paper
• The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets.

  2022cites this paper
• Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines

  2022cites this paper
• Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma

  2022cites this paper
• EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma

  2022cites this paper
• PRMT5 as a Novel Druggable Vulnerability for EWSR1-ATF1-driven Clear Cell Sarcoma

  2022influential citation
• The clear cell sarcoma functional genomic landscape.

  2021cites this paper
• Genetic drivers and cells of origin in sarcomagenesis

  2021cites this paper
• Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2

  2021cites this paper
• Modeling fusion gene‐associated sarcoma: Advantages for understanding sarcoma biology and pathology

  2021cites this paper
• Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop.

  2021cites this paper
• Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.

  2021cites this paper
• Current Approaches for Personalized Therapy of Soft Tissue Sarcomas

  2020cites this paper
• Sarcoma Pathology and Biology

  2020cites this paper
• Clear Cell Sarcoma

  2020cites this paper
• A suite of bioassays to evaluate CREB inhibitors.

  2020cites this paper
• Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 as a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.

  2019cites this paper
• Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas

  2019cites this paper
• CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model

  2019cites this paper
• Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.

  2018cites this paper
• A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer.

  2018cites this paper
• An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva

  2018cites this paper
• Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma

  2017cites this paper
• Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.

  2017cites this paper
• Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

  2016cites this paper
• An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development

  2016cites this paper
• Prospect of Human Pluripotent Stem Cell-Derived Neural Crest Stem Cells in Clinical Application

  2016cites this paper
• Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines

  2015cites this paper
• SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier

  2015cites this paper
• Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation.

  2014cites this paper
• The stemness of neural crest cells and their derivatives.

  2014cites this paper
• Molecular Testing in Bone and Soft Tissue Tumors

  2014cites this paper
• Neural Crest Cells and Cancer: Insights into Tumor Progression

  2014cites this paper
• Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

  2014cites this paper
• A rare case of clear cell sarcoma with 4 types of EWSR1-ATF1 fusions detected not in primary site but in metastatic site.

  2013cites this paper